WebOrchestra BioMed, Inc. operates as a therapeutic device company. The Company focuses on the development of interventional devices, bioelectronics, and neuromodulation for the … WebJun 13, 2024 · Orchestra BioMed is a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine. The company partners with established market leaders to drive global commercialization of its products, establishing multiple long-term potential revenue streams and supporting further product development.
Ph.D. Programs Graduate Studies MUSC
WebJul 6, 2024 · Orchestra BioMed Holdings is expected have a fully diluted pro forma market cap of $407 million and an enterprise value of $158 million. It will be led by David Hochman, the chairman, CEO and... WebOrchestra BioMed is a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine. The company partners with established … owen hatherley
Orchestra BioMed™ Announces Peer-Reviewed ... - Cardiac Vascular News
WebMar 31, 2024 · Orchestra Biomed Hldgs Inc (OBIO) Try Excel Alerts Watch Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals See More Market Capitalization, $K 227,043 Shares Outstanding, K 11,212 Annual Sales, $ -782 K Annual Income, $ -2,740 K 60-Month Beta 0.33 Price/Sales 4,355.00 Price/Cash Flow N/A WebSep 20, 2024 · NEW HOPE, Pa., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed™, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to... WebOrchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine. New Hope, Pennsylvania, United States 11-50 www.orchestrabiomed.com/ 2,061 Highlights Stock Symbol NASDAQ:OBIO Investments 1 Total Funding Amount $282.8M Employee Profiles 6 Contacts 13 Investors 8 owen hart wwf